quinta-feira, janeiro 06, 2005
Kivexa aprovado pela EMEA
Mais um comprimido "dois-em-um" no mercado europeu.
The Body 23.12.04
GSK Gains European Approval for Combination Antiretroviral Drug Kivexa
GlaxoSmithKline on Wednesday announced that it has received marketing approval from the European Commission for its antiretroviral drug Kivexa, which is a once-a-day tablet that combines the company's Epivir and Ziagen, known generically as lamivudine and abacavir, respectively, Reuters reports.